Vimedimex Medi-Pharma JSC

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is -31.95% vs -68.22% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 39.35% vs -28.50% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "241,273.80",
          "val2": "354,538.00",
          "chgp": "-31.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,590.90",
          "val2": "7,120.40",
          "chgp": "-63.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.90",
          "val2": "705.10",
          "chgp": "-97.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,872.20",
          "val2": "2,778.80",
          "chgp": "39.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.40%",
          "val2": "13.60%",
          "chgp": "-1.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -64.73% vs -49.90% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -24.86% vs -10.88% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,249,868.10",
          "val2": "3,543,979.60",
          "chgp": "-64.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27,631.90",
          "val2": "52,568.50",
          "chgp": "-47.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3,703.00",
          "val2": "1,755.40",
          "chgp": "110.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "241.80",
          "val2": "557.50",
          "chgp": "-56.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "22,375.00",
          "val2": "29,777.60",
          "chgp": "-24.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.40%",
          "val2": "10.70%",
          "chgp": "-0.63%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY

Mar'25

Mar'24

Change(%)

Net Sales

241,273.80

354,538.00

-31.95%

Operating Profit (PBDIT) excl Other Income

2,590.90

7,120.40

-63.61%

Interest

14.90

705.10

-97.89%

Exceptional Items

0.00

0.00

Consolidate Net Profit

3,872.20

2,778.80

39.35%

Operating Profit Margin (Excl OI)

-2.40%

13.60%

-1.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2025 is -31.95% vs -68.22% in Mar 2024

Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is 39.35% vs -28.50% in Mar 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,249,868.10

3,543,979.60

-64.73%

Operating Profit (PBDIT) excl Other Income

27,631.90

52,568.50

-47.44%

Interest

3,703.00

1,755.40

110.95%

Exceptional Items

241.80

557.50

-56.63%

Consolidate Net Profit

22,375.00

29,777.60

-24.86%

Operating Profit Margin (Excl OI)

4.40%

10.70%

-0.63%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -64.73% vs -49.90% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -24.86% vs -10.88% in Dec 2023

All Annual Results